NO971110L - Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin - Google Patents

Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin

Info

Publication number: NO971110L
Authority: NO; Norway
Prior art keywords: pallidipine; asp; platelet aggregation; amino acid; aspartic acid
Prior art date: 1994-09-12

Application number

NO971110A

Other languages

English (en)

Norwegian (no)

Other versions

NO971110D0 (no

Inventor

Christiane Noeske-Jungblut

Andreas Becker

Bernard Haendler

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-12

Filing date

1997-03-11

Publication date

1997-05-07

1997-03-11 Application filed by Schering Ag filed Critical Schering Ag

1997-03-11 Publication of NO971110D0 publication Critical patent/NO971110D0/no

1997-05-07 Publication of NO971110L publication Critical patent/NO971110L/no

Links

102000008186 Collagen Human genes 0.000 title abstract 3
108010035532 Collagen Proteins 0.000 title abstract 3
229920001436 collagen Polymers 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
238000002360 preparation method Methods 0.000 title abstract 2
101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 title 1
101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 title 1
229940127218 antiplatelet drug Drugs 0.000 title 1
239000000106 platelet aggregation inhibitor Substances 0.000 title 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 4
150000001413 amino acids Chemical class 0.000 abstract 3
235000003704 aspartic acid Nutrition 0.000 abstract 3
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 3
235000018102 proteins Nutrition 0.000 abstract 3
102000004169 proteins and genes Human genes 0.000 abstract 3
108090000623 proteins and genes Proteins 0.000 abstract 3
108010076504 Protein Sorting Signals Proteins 0.000 abstract 2
235000001014 amino acid Nutrition 0.000 abstract 2
210000001322 periplasm Anatomy 0.000 abstract 2
208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
108091005804 Peptidases Proteins 0.000 abstract 1
239000004365 Protease Substances 0.000 abstract 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
230000001580 bacterial effect Effects 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
238000003776 cleavage reaction Methods 0.000 abstract 1
239000002299 complementary DNA Substances 0.000 abstract 1
210000000805 cytoplasm Anatomy 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
238000000605 extraction Methods 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
238000002955 isolation Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
206010061289 metastatic neoplasm Diseases 0.000 abstract 1
238000000746 purification Methods 0.000 abstract 1
230000007017 scission Effects 0.000 abstract 1
210000004881 tumor cell Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Hematology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO971110A 1994-09-12 1997-03-11 Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin NO971110L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP94250224		1994-09-12
PCT/EP1995/003573 WO1996008563A1 (en)	1994-09-12	1995-09-11	Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Publications (2)

Publication Number	Publication Date
NO971110D0 NO971110D0 (no)	1997-03-11
NO971110L true NO971110L (no)	1997-05-07

Family

ID=8217517

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO971110A NO971110L (no)	1994-09-12	1997-03-11	Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin

Country Status (22)

Country	Link
US (1)	US5882887A (pl)
EP (1)	EP0781334A1 (pl)
JP (1)	JPH10505502A (pl)
CN (1)	CN1075836C (pl)
AU (1)	AU701643B2 (pl)
BG (1)	BG63276B1 (pl)
BR (1)	BR9508910A (pl)
CA (1)	CA2199719A1 (pl)
CZ (1)	CZ76297A3 (pl)
FI (1)	FI971013A7 (pl)
HU (1)	HU222398B1 (pl)
IL (1)	IL115272A0 (pl)
MX (1)	MX9701720A (pl)
NO (1)	NO971110L (pl)
NZ (1)	NZ293261A (pl)
PL (1)	PL184617B1 (pl)
RO (1)	RO117971B1 (pl)
RU (1)	RU2186110C2 (pl)
SI (1)	SI9520093A (pl)
SK (1)	SK29297A3 (pl)
WO (1)	WO1996008563A1 (pl)
ZA (1)	ZA957649B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL200384B1 (pl) *	1999-03-18	2008-12-31	Merck Patent Gmbh	Polipeptyd blokujący adhezję płytek krwi, sposób jego otrzymywania, zastosowanie i zawierający go preparat farmaceutyczny
JP2008525000A (ja) *	2004-12-28	2008-07-17	アレストレーディングエス．エー．	統合失調症及び関連障害を治療するための組成物及び方法
US20110034396A1 (en) *	2005-09-28	2011-02-10	Biovascular, Inc.	Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
CA2623565A1 (en) *	2005-09-28	2007-04-05	Biovascular, Inc.	Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
TWI391143B (zh) *	2005-11-04	2013-04-01	Otsuka Pharma Co Ltd	血小板凝集抑制劑組成物
US9617302B2 (en) *	2011-06-14	2017-04-11	National Taiwan University	Peptide compounds for inhibition of platelet aggregation
FR2979346B1 (fr)	2011-08-23	2013-09-27	Univ Joseph Fourier	Nanocorps anti-vcam-1
SG11201404741VA (en)	2012-02-07	2014-09-26	Global Bio Therapeutics Usa Inc	Compartmentalized method of nucleic acid delivery and compositions and uses thereof
ES2797625T3 (es)	2012-09-07	2020-12-03	Inst Nat Sante Rech Med	Péptidos inhibitorios derivados del receptor desencadenante expresado en células mieloides-1 (TREM-1) y del transcrito similar a TREM 1 (TLT-1) y sus usos
CN105813579B (zh)	2013-08-08	2019-05-07	全球生物疗法有限公司	用于微创手术过程的夹具装置和其应用
FR3058143B1 (fr)	2016-10-27	2021-03-12	Univ Grenoble Alpes	Nanocorps anti-tau
US20240366681A1 (en)	2021-08-13	2024-11-07	Triovance Holding Llc	A skin substitute composition and methods of producing and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI896261A7 (fi) *	1987-06-24	1989-12-22	Novo Nordisk As	Menetelmä proteiinin tai polypeptidin valmistamiseksi, polypeptidiä ko odaava DNA-sekvenssi, DNA-sekvenssin sisältämä mikro-organismi sekä po lypeptidi ja sen käyttö farmaseuttisena valmisteena
US5756454A (en) *	1991-09-05	1998-05-26	Schering Aktiengesellschaft	Collagen-induced platelet aggregation inhibitor
DE69226580T2 (de) *	1991-09-05	1999-03-04	Schering Ag, 13353 Berlin	Hemmstoff der Kollagen-induzierten Plättchenaggregation
US5705362A (en) *	1992-05-25	1998-01-06	Gist-Brocades, N.V.	Modified signal sequences

1995
- 1995-09-11 RO RO97-00444A patent/RO117971B1/ro unknown
- 1995-09-11 RU RU97105821/13A patent/RU2186110C2/ru not_active IP Right Cessation
- 1995-09-11 AU AU35657/95A patent/AU701643B2/en not_active Ceased
- 1995-09-11 US US08/793,294 patent/US5882887A/en not_active Expired - Fee Related
- 1995-09-11 CA CA002199719A patent/CA2199719A1/en not_active Abandoned
- 1995-09-11 NZ NZ293261A patent/NZ293261A/en unknown
- 1995-09-11 SK SK292-97A patent/SK29297A3/sk unknown
- 1995-09-11 CZ CZ97762A patent/CZ76297A3/cs unknown
- 1995-09-11 BR BR9508910A patent/BR9508910A/pt not_active Application Discontinuation
- 1995-09-11 SI SI9520093A patent/SI9520093A/sl unknown
- 1995-09-11 JP JP8509898A patent/JPH10505502A/ja not_active Ceased
- 1995-09-11 MX MX9701720A patent/MX9701720A/es unknown
- 1995-09-11 WO PCT/EP1995/003573 patent/WO1996008563A1/en not_active Ceased
- 1995-09-11 CN CN95195002A patent/CN1075836C/zh not_active Expired - Fee Related
- 1995-09-11 HU HU9701823A patent/HU222398B1/hu not_active IP Right Cessation
- 1995-09-11 PL PL95319078A patent/PL184617B1/pl unknown
- 1995-09-11 EP EP95932714A patent/EP0781334A1/en not_active Withdrawn
- 1995-09-12 ZA ZA957649A patent/ZA957649B/xx unknown
- 1995-09-12 IL IL11527295A patent/IL115272A0/xx unknown
1997
- 1997-02-12 BG BG101226A patent/BG63276B1/bg unknown
- 1997-03-11 FI FI971013A patent/FI971013A7/fi unknown
- 1997-03-11 NO NO971110A patent/NO971110L/no unknown

Also Published As

Publication number	Publication date
RO117971B1 (ro)	2002-11-29
HU222398B1 (hu)	2003-06-28
ZA957649B (en)	1996-04-15
NZ293261A (en)	1998-11-25
CA2199719A1 (en)	1996-03-21
BG101226A (bg)	1998-10-30
SI9520093A (en)	1997-08-31
CN1075836C (zh)	2001-12-05
NO971110D0 (no)	1997-03-11
RU2186110C2 (ru)	2002-07-27
WO1996008563A1 (en)	1996-03-21
CN1159828A (zh)	1997-09-17
EP0781334A1 (en)	1997-07-02
PL184617B1 (pl)	2002-11-29
PL319078A1 (en)	1997-07-21
MX9701720A (es)	1997-06-28
SK29297A3 (en)	1997-10-08
AU701643B2 (en)	1999-02-04
HUT76972A (hu)	1998-01-28
AU3565795A (en)	1996-03-29
CZ76297A3 (cs)	1998-01-14
IL115272A0 (en)	1995-12-31
US5882887A (en)	1999-03-16
FI971013A0 (fi)	1997-03-11
FI971013A7 (fi)	1997-03-11
JPH10505502A (ja)	1998-06-02
BG63276B1 (bg)	2001-08-31
BR9508910A (pt)	1997-10-28

Similar Documents

Publication	Publication Date	Title
George-Nascimento et al.	1988	Characterization of recombinant human epidermal growth factor produced in yeast
Steiner et al.	1984	Golgi/granule processing of peptide hormone and neuropeptide precursors: a minireview
Mutt et al.	1974	Structure of the Porcine Vasoactive Intestinal Octacosapeptide: The Amino‐Acid Sequence. Use of Kallikrein in Its Determination
ES2254658T3 (es)	2006-06-16	Proteina de fusion que comprende hirudina y proinsulina o insulina.
DK1356073T3 (da)	2010-04-06	Fermenteringsfremgangsmåde til fremstilling af heterologe genprodukter i mælkesyrebakterier
CA2032153A1 (fr)	1990-10-29	Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
CZ636081A3 (en)	1995-02-15	Process for preparing a vector for dna transfer
Claeys et al.	1976	Multiple gene duplication in the evolution of plasminogen. Five regions of sequence homology with the two internally homologous structures in prothrombin
US9056922B2 (en)	2015-06-16	Chimeric relaxin polypeptides comprising an A and B chain derived from different relaxin family peptides
RU2010127232A (ru)	2012-01-10	Рекомбинантные белки эластазы и способы их получения и применения
AU1550095A (en)	1996-07-24	Generation of human insulin
DE69906509D1 (de)	2003-05-08	Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen
WO2022227707A1 (zh)	2022-11-03	一种双靶点融合蛋白的制备方法和应用
MX9701720A (es)	1997-06-28	Proceso para la fabricacion de una palidipina modificada, inhibidora de la agregacion plaquetaria inducida por colageno.
US5218093A (en)	1993-06-08	EGF variants and pharmaceutical use thereof
ATE408016T1 (de)	2008-09-15	Verfahren zur herstellung und sekretion modifizierter peptide
ZA916171B (en)	1992-04-29	Protein structure of the plant toxin gelonin
Lane et al.	1981	The sequestration, processing and retention of honey‐bee promelittin made in amphibian oocytes
RU97105821A (ru)	1999-05-27	Способ производства модифицированного ингибитора индуцированной коллагеном агрегации тромбоцитов паллидипина
EP0437544A4 (en)	1991-11-06	Recombinant pdgf and methods for production
CA2198966A1 (en)	1997-09-04	Method for cleaving chimeric protein using processing enzyme
ATE152772T1 (de)	1997-05-15	Verhindern von spaltung von n-terminalen aminosäuren durch endogene aminopeptidasen während die expression von fremden genen in bakterien
WO2013015697A1 (en)	2013-01-31	A recombinant protein, a polynucleotide encoding it as well as a method of obtaining insulin or its an analogue
CN102993309B (zh)	2014-12-03	一种人生长素融合蛋白TAT-hGH及其制备方法和应用
Honjo et al.	1986	Secretion of human growth hormone in Bacillus subtilis using prepropeptide coding region of Bacillus amyloliquefaciens neutral protease gene